| pubmed-article:18955454 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C1506770 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
| pubmed-article:18955454 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18955454 | pubmed:issue | 34 | lld:pubmed |
| pubmed-article:18955454 | pubmed:dateCreated | 2008-11-27 | lld:pubmed |
| pubmed-article:18955454 | pubmed:abstractText | Lapatinib, a dual tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR/ErbB1) and human epidermal growth factor receptor 2 (HER-2/ErbB2), is effective against HER-2-positive locally advanced or metastatic breast cancer (MBC). This phase III trial evaluated the efficacy of lapatinib in HER-2-negative and HER-2-uncharacterized MBC. | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18955454 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18955454 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18955454 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18955454 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18955454 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:Di LeoAngeloA | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:AzizZebaZ | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:PressMichael... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:KoehlerMariaM | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:SteinSteven... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:DeringJudyJ | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:FinnRichard... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:GomezHenry... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:OlivaCristina... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:BinesJoseJ | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:ArbushitesMic... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:ZvirbuleZanet... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:GuerreraSteph... | lld:pubmed |
| pubmed-article:18955454 | pubmed:author | pubmed-author:WilliamsLisa... | lld:pubmed |
| pubmed-article:18955454 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18955454 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18955454 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:18955454 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18955454 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18955454 | pubmed:pagination | 5544-52 | lld:pubmed |
| pubmed-article:18955454 | pubmed:dateRevised | 2010-9-21 | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:meshHeading | pubmed-meshheading:18955454... | lld:pubmed |
| pubmed-article:18955454 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18955454 | pubmed:articleTitle | Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. | lld:pubmed |
| pubmed-article:18955454 | pubmed:affiliation | Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy 59100. adileo@usl4.toscana.it | lld:pubmed |
| pubmed-article:18955454 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18955454 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18955454 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18955454 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18955454 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| pubmed-article:18955454 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18955454 | lld:pubmed |
